Du, J., Lopez-Verges, S., Pitcher, B. N., Johnson, J., Jung, S., Zhou, L., . . . Venstrom, J. M. (2014). CALGB 150905 (Alliance): Rituximab broadens the anti-lymphoma response by activating unlicensed NK cells. Cancer Immunol Res.
Citação norma ChicagoDu, Juan, et al. "CALGB 150905 (Alliance): Rituximab Broadens the Anti-lymphoma Response By Activating Unlicensed NK Cells." Cancer Immunol Res 2014.
Deismireacht MLADu, Juan, et al. "CALGB 150905 (Alliance): Rituximab Broadens the Anti-lymphoma Response By Activating Unlicensed NK Cells." Cancer Immunol Res 2014.
Rabhadh: D'fhéadfadh nach mbeadh na deismireachtaí seo 100% cruinn i gcónaí.